Fifth Lane Capital’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Fifth Lane Capital’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-3,000	Closed	-$301K	–	154
2025 Q3	$301K	Sell	3,000 -1,500	-33%	-$135K	0.3%	58
2025 Q2	$373K	Buy	+4,500	New	+$359K	0.45%	36
2024 Q4	–	Sell	-3,000	Closed	-$296K	–	54
2024 Q3	$296K	Buy	+3,000	New	+$295K	0.75%	19
2022 Q3	–	Sell	-3,106	Closed	-$231K	–	251
2022 Q2	$231K	Buy	+3,106	New	+$233K	0.15%	144

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Fifth Lane Capital's XBI Position: Q4 2025 in Review

Fifth Lane Capital sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2025, closing a stake of 3,000 shares — an estimated $301K sold.

Fifth Lane Capital first reported a position in XBI in Q2 2022 and held it in 4 quarters. The position peaked at $373K in Q2 2025. 813 funds tracked by Wall St. Rank hold XBI as of Q4 2025.

Fifth Lane Capital reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2025 after selling out during the quarter.
Fifth Lane Capital sold 3,000 State Street SPDR S&P Biotech ETF shares in Q4 2025, an estimated $301K.
Fifth Lane Capital first reported a position in State Street SPDR S&P Biotech ETF in Q2 2022 and held it in 4 quarters.
Fifth Lane Capital's State Street SPDR S&P Biotech ETF position peaked at $373K in Q2 2025.
813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2025.

Based on Fifth Lane Capital's 13F filing for Q4 2025, filed 13 Feb 2026.